ArticleAmerican journal of translational research2023

Epigenetic differences in NCOA2: a novel biomarker that predicts prognosis in clear cell renal cell carcinoma.

Zhixian Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.